Tandem Diabetes Care, Inc. (TNDM) Analyst Forecast

$35.78

south_east
-$0.43 (-1.19%)
Day's range
$35.46
Day's range
$36.7

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
01/08/2025 Bernstein Lee Hambright $44.00 $37.49   17.36%
11/07/2024 Robert W. Baird Jeff Johnson $37.00 $32.87   12.56%
11/05/2024 Bernstein Lee Hambright $42.00 $33.11   26.85%
10/04/2024 Goldman Sachs David Roman $46.00 $39.99   15.03%
10/02/2024 RBC Capital Shagun Singh $65.00 $41.07   58.27%
08/08/2024 Canaccord Genuity William Plovanic $57.00 $37.04   53.89%
08/05/2024 Barclays Matt Miksic $58.00 $41.67   39.19%
08/02/2024 Piper Sandler Matt O'Brien $55.00 $35.21   56.21%
08/02/2024 Robert W. Baird Jeff Johnson $39.00 $35.21   10.76%
06/10/2024 Oppenheimer Steven Lichtman $58.00 $47.03   23.33%
05/29/2024 Stifel Nicolaus Matthew Blackman $60.00 $51.93   15.55%
05/22/2024 Lake Street Brooks O'Neil $75.00 $49.32   52.07%
05/03/2024 Piper Sandler Matt O'Brien $50.00 $36.56   36.76%
05/03/2024 Robert W. Baird Jeff Johnson $36.00 $36.56   -1.53%
04/29/2024 Wells Fargo Lawrence Biegelsen $45.00 $37.55   19.84%
04/25/2024 Leerink Partners Danielle AntalffyMike Kratky $45.00 $35.35   27.3%
04/22/2024 Stifel Nicolaus Matthew Blackman $40.00 $31.73   26.06%
04/11/2024 CFRA Kenneth Leon $36.00 $33.87   6.29%
03/25/2024 Stifel Nicolaus Mathew Blackman $37.00 $30.10   22.92%
08/09/2022 Wells Fargo Larry Biegelsen $49.00 $60.10   -18.47%
08/04/2022 Piper Sandler Matt O'Brien $80.00 $68.97   15.99%
05/05/2022 Piper Sandler Matt O'Brien $120.00 $94.43   27.08%
11/03/2021 Cowen & Co. Josh Jennings $141.00 $132.51   6.41%
11/03/2021 Berenberg Bank Ravi Misra $147.00 $132.51   10.94%
08/04/2021 Craig-Hallum Alexander Nowak $153.00 $109.97   39.13%
08/04/2021 UBS Matthew Taylor $160.00 $109.97   45.49%

Tandem Diabetes Care, Inc. FAQ's

What analysts cover Tandem Diabetes Care, Inc.?

Tandem Diabetes Care, Inc. has been rated by research analysts at Bernstein, Robert W. Baird, Goldman Sachs, RBC Capital, Canaccord Genuity, Barclays in the past 90 days.